REGN Snapshot
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Market Capitalization$83,461,407,000
Price to Sales6.09
Earnings per Share$49.3600
PE Ratio15.53
Most Recent Close$766.3900
52 Week High$769.63
52 Week Low$538.01
50-Day Moving Average$733.09
200-Day Moving Average$662.63
All data are from Alpha Vantage as of today. For more infomation on REGN see Stock Dividend, Valuation, Price and Financial Data for Investors